Pediatric stroke: What do we know and what do we need to know?

被引:54
作者
Lynch, JK [1 ]
Han, CJ [1 ]
机构
[1] NINDS, Neuroepidemiol Branch, Bethesda, MD 20892 USA
关键词
cerebrovascular diseases; child;
D O I
10.1055/s-2005-923535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Stroke is a heterogeneous disorder and an important cause of mortality and chronic morbidity in children. Estimates of international incidence rates for childhood stroke have varied widely. Arterial ischemic stroke is reported to be more common than hemorrhagic stroke in children. The clinical presentation of stroke in children differs according to the child's age and stroke type and location. Several risk factors for ischemic and hemorrhagic stroke in children have been reported and include cardiac disorders, blood disorders, vasculopathies, viral infections, and arteriovenous malformations. Current treatment recommendations for stroke in children are based on small nonrandomized trials, adult stroke studies, case series, or consensus or individual expert opinion. Over half of children with stroke will develop lifelong cognitive or motor disability, and up to a third will have a recurrent stroke. International studies have provided important information on stroke in children, but major gaps in our knowledge of the disorder still exist. Currently, there is a need for prospective cohort studies in diverse populations, which utilize a consensus pediatric stroke classification system and a standard evaluation of risk factors and outcome, so that treatment and prevention strategies can be developed.
引用
收藏
页码:410 / 423
页数:14
相关论文
共 137 条
[1]   Natural history, prognosis, and lipid abnormalities of idiopathic ischemic childhood stroke [J].
Abram, HS ;
Knepper, LE ;
Warty, VS ;
Painter, MJ .
JOURNAL OF CHILD NEUROLOGY, 1996, 11 (04) :276-282
[2]   Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].
Adams, RJ ;
McKie, VC ;
Hsu, L ;
Files, B ;
Vichinsky, E ;
Pegelow, C ;
Abboud, M ;
Gallagher, D ;
Kutlar, A ;
Nichols, FT ;
Bonds, DR ;
Brambilla, D ;
Woods, G ;
Olivieri, N ;
Driscoll, C ;
Miller, S ;
Wang, W ;
Hurlett, A ;
Scher, C ;
Berman, B ;
Carl, E ;
Jones, AM ;
Roach, ES ;
Wright, E ;
Zimmerman, RA ;
Waclawiw, M ;
Pearson, H ;
Powars, D ;
Younkin, D ;
El-Gammal, T ;
Seibert, J ;
Moye, L ;
Espeland, M ;
Murray, R ;
McKinley, R ;
McKinley, S ;
Hagner, S ;
Weiner, S ;
Estow, S ;
Yelle, M ;
Brock, K ;
Carter, E ;
Chiarucci, K ;
Debarr, M ;
Feron, P ;
Harris, S ;
Hoey, L ;
Jacques, K ;
Kuisel, L ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11
[3]   Stroke prevention and treatment in sickle cell disease [J].
Adams, RJ .
ARCHIVES OF NEUROLOGY, 2001, 58 (04) :565-568
[4]  
Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31
[5]   Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct [J].
Akar, N ;
Akar, E ;
Deda, G ;
Sipahi, T ;
Orsal, A .
JOURNAL OF CHILD NEUROLOGY, 1999, 14 (11) :749-751
[6]   Nontraumatic brain hemorrhage in children: Etiology and presentation [J].
Al-Jarallah, A ;
Al-Rifai, MT ;
Riela, AR ;
Roach, ES .
JOURNAL OF CHILD NEUROLOGY, 2000, 15 (05) :284-289
[7]  
Andrew M., 2000, THROMBOEMBOLIC COMPL
[8]  
ANDREW M, 1999, PEDIAT THROMBOEMBOLI
[9]  
[Anonymous], 2004, STROK CHILDH CLIN GU
[10]  
Arias Elizabeth, 2003, Natl Vital Stat Rep, V52, P1